Citigroup’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.25M | Sell |
52,432
-32,504
| -38% | -$777K | ﹤0.01% | 2381 |
|
2025
Q1 | $2.11M | Buy |
84,936
+7,377
| +10% | +$183K | ﹤0.01% | 2047 |
|
2024
Q4 | $1.46M | Sell |
77,559
-13,030
| -14% | -$245K | ﹤0.01% | 2342 |
|
2024
Q3 | $1.36M | Buy |
90,589
+48,786
| +117% | +$734K | ﹤0.01% | 2327 |
|
2024
Q2 | $1.2M | Buy |
41,803
+3,780
| +10% | +$108K | ﹤0.01% | 2137 |
|
2024
Q1 | $1.11M | Sell |
38,023
-1,096
| -3% | -$32K | ﹤0.01% | 2282 |
|
2023
Q4 | $1.32M | Sell |
39,119
-14,042
| -26% | -$474K | ﹤0.01% | 1958 |
|
2023
Q3 | $1.63M | Buy |
53,161
+9,668
| +22% | +$297K | ﹤0.01% | 1591 |
|
2023
Q2 | $1.74M | Buy |
43,493
+15,301
| +54% | +$613K | ﹤0.01% | 1797 |
|
2023
Q1 | $1.15M | Sell |
28,192
-4,469
| -14% | -$182K | ﹤0.01% | 1900 |
|
2022
Q4 | $1.26M | Buy |
32,661
+3,541
| +12% | +$137K | ﹤0.01% | 1845 |
|
2022
Q3 | $1.55M | Buy |
29,120
+639
| +2% | +$34K | ﹤0.01% | 1780 |
|
2022
Q2 | $1.66M | Sell |
28,481
-21,121
| -43% | -$1.23M | ﹤0.01% | 1705 |
|
2022
Q1 | $3.79M | Buy |
49,602
+4,878
| +11% | +$372K | ﹤0.01% | 1332 |
|
2021
Q4 | $2.69M | Sell |
44,724
-15,296
| -25% | -$920K | ﹤0.01% | 1752 |
|
2021
Q3 | $3.36M | Buy |
60,020
+10,270
| +21% | +$575K | ﹤0.01% | 1519 |
|
2021
Q2 | $3.02M | Buy |
49,750
+23,995
| +93% | +$1.46M | ﹤0.01% | 1798 |
|
2021
Q1 | $1.81M | Sell |
25,755
-10,655
| -29% | -$747K | ﹤0.01% | 1994 |
|
2020
Q4 | $2.18M | Buy |
36,410
+5,412
| +17% | +$324K | ﹤0.01% | 1652 |
|
2020
Q3 | $1.86M | Sell |
30,998
-15,545
| -33% | -$935K | ﹤0.01% | 1552 |
|
2020
Q2 | $2.44M | Buy |
46,543
+14,980
| +47% | +$786K | ﹤0.01% | 1485 |
|
2020
Q1 | $1.06M | Sell |
31,563
-8,680
| -22% | -$291K | ﹤0.01% | 1773 |
|
2019
Q4 | $1.82M | Buy |
40,243
+8,330
| +26% | +$377K | ﹤0.01% | 1756 |
|
2019
Q3 | $1.22M | Sell |
31,913
-8,942
| -22% | -$340K | ﹤0.01% | 1975 |
|
2019
Q2 | $1.78M | Buy |
40,855
+8,191
| +25% | +$356K | ﹤0.01% | 1724 |
|
2019
Q1 | $1.24M | Sell |
32,664
-16,404
| -33% | -$624K | ﹤0.01% | 1828 |
|
2018
Q4 | $2.11M | Sell |
49,068
-4,348
| -8% | -$187K | ﹤0.01% | 1497 |
|
2018
Q3 | $2.63M | Buy |
53,416
+16,455
| +45% | +$809K | ﹤0.01% | 1350 |
|
2018
Q2 | $1.19M | Sell |
36,961
-1,358
| -4% | -$43.5K | ﹤0.01% | 1763 |
|
2018
Q1 | $1.19M | Sell |
38,319
-6,437
| -14% | -$200K | ﹤0.01% | 1721 |
|
2017
Q4 | $2.04M | Sell |
44,756
-29,761
| -40% | -$1.36M | ﹤0.01% | 1466 |
|
2017
Q3 | $2.8M | Sell |
74,517
-22,264
| -23% | -$836K | ﹤0.01% | 1284 |
|
2017
Q2 | $4.62M | Buy |
96,781
+93,790
| +3,136% | +$4.47M | ﹤0.01% | 988 |
|
2017
Q1 | $136K | Sell |
2,991
-10,623
| -78% | -$483K | ﹤0.01% | 3180 |
|
2016
Q4 | $440K | Sell |
13,614
-49,927
| -79% | -$1.61M | ﹤0.01% | 2997 |
|
2016
Q3 | $2.17M | Buy |
63,541
+55,981
| +740% | +$1.92M | ﹤0.01% | 1359 |
|
2016
Q2 | $255K | Sell |
7,560
-29,900
| -80% | -$1.01M | ﹤0.01% | 2689 |
|
2016
Q1 | $1.99M | Buy |
37,460
+17,428
| +87% | +$924K | ﹤0.01% | 1436 |
|
2015
Q4 | $1.54M | Sell |
20,032
-9,465
| -32% | -$727K | ﹤0.01% | 1483 |
|
2015
Q3 | $1.21M | Sell |
29,497
-2,667
| -8% | -$110K | ﹤0.01% | 1592 |
|
2015
Q2 | $2.27M | Buy |
32,164
+400
| +1% | +$28.3K | ﹤0.01% | 1255 |
|
2015
Q1 | $2.82M | Buy |
31,764
+11,091
| +54% | +$985K | ﹤0.01% | 1164 |
|
2014
Q4 | $1.83M | Buy |
20,673
+18,535
| +867% | +$1.64M | ﹤0.01% | 1318 |
|
2014
Q3 | $207K | Buy |
2,138
+292
| +16% | +$28.3K | ﹤0.01% | 2630 |
|
2014
Q2 | $170K | Sell |
1,846
-5,749
| -76% | -$529K | ﹤0.01% | 2706 |
|
2014
Q1 | $531K | Sell |
7,595
-6,314
| -45% | -$441K | ﹤0.01% | 2038 |
|
2013
Q4 | $799K | Buy |
13,909
+7,322
| +111% | +$421K | ﹤0.01% | 2012 |
|
2013
Q3 | $317K | Buy |
6,587
+5,998
| +1,018% | +$289K | ﹤0.01% | 2281 |
|
2013
Q2 | $18K | Buy |
+589
| New | +$18K | ﹤0.01% | 4237 |
|